Legend Biotech USA Revenue and Competitors
Estimated Revenue & Valuation
- Legend Biotech USA's estimated annual revenue is currently $93.5M per year.
- Legend Biotech USA's estimated revenue per employee is $90,397
- Legend Biotech USA's total funding is $150.5M.
- Legend Biotech USA's current valuation is $6.3B. (January 2022)
Employee Data
- Legend Biotech USA has 1034 Employees.
- Legend Biotech USA grew their employee count by 2% last year.
Legend Biotech USA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $10.9M | 45 | -21% | N/A | N/A |
#2 | $0.9M | 1 | 0% | N/A | N/A |
#3 | $11.9M | 45 | -29% | N/A | N/A |
#4 | $106.8M | 410 | 2% | N/A | N/A |
#5 | $1.4M | 4 | 0% | N/A | N/A |
#6 | $0.9M | 3 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1232 | -15% | $568M | N/A |
#9 | $2.5M | 6 | -40% | N/A | N/A |
#10 | $4.5M | 24 | 0% | N/A | N/A |
What Is Legend Biotech USA?
Legend Biotech Corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. Teamed up with outstanding immunologists and molecular biologists, Legend has generated a strong pipeline of Chimeric Antigen Receptor(CAR) product candidates to treat a wide variety of liquid and solid tumors. Our ambition to succeed in the CARs field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. By applying one of our proprietary CAR-T technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. Legend Biotech Corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. We take our mission very seriously and intend to bring more hopes to desperate patients all over the world.
keywords:N/A
$150.5M
Total Funding
1034
Number of Employees
$93.5M
Revenue (est)
2%
Employee Growth %
$6.3B
Valuation
N/A
Accelerator
Legend Biotech USA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chairman the Board at Legend Biotech | Reveal Email/Phone |
2 | Senior Cell Therapy Account Specialist- (CAR-T Therapy) | Reveal Email/Phone |
3 | Associate Director Finance | Reveal Email/Phone |
4 | Associate Principal, Ethics and Compliance Operations | Reveal Email/Phone |
5 | Senior Director | Reveal Email/Phone |
6 | CAR-T Senior Regional Sales Leader -- East | Reveal Email/Phone |
7 | Director, Medical Affairs, Scientific Communications Lead | Reveal Email/Phone |
8 | Senior Director, Global Marketing & Strategy | Reveal Email/Phone |
9 | Senior Medical Science Liaison | Reveal Email/Phone |
10 | Sr. Cell Therapy Account Specialist | Reveal Email/Phone |
Legend Biotech USA News
Legend Biotech USA Inc., of Somerset, N.J., achieved a $50 million milestone under its collaboration agreement with Janssen Biotech Inc.,...
... with Legend Biotech USA Inc to develop and commercialize cilta-cel. ... The US Food and Drug Administration (FDA) approved the Janssen...
Legend Biotech Announces Advancement of Global Manufacturing Infrastructure New Cell Therapy Facility in Belgium Establishes Manufacturing Presence in the European Union New facility builds upon Legend Biotech's collaboration with Janssen to advance the manufacturing of investigational CAR-T t ...
Premium Legend Star, an early-stage focused investment firm set up by Lenovo Holdings, has closed its fourth RMB-denominated fund at 800 million yuan ($119 million) in September, per its announcement on Monday. Continue reading this story with a subscription to DealStreetAsia. Subscribe Alre ...
Legend Mining Limited ('Legend') is pleased to announce that it has obtained binding commitments from existing major shareholders, and a range of institutional and sophisticated investors for a capital raising of $20 million ('Placement'). Funds raised via the Placement will be applied to progr ...
Other Companies in Piscataway
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $269.1M | 1085 | 8% | $11.2M |
#2 | $750M | 1229 | 8% | N/A |
#3 | $75M | 1848 | 26% | N/A |
#4 | $405.2M | 1996 | N/A | N/A |
#5 | $482.7M | 2463 | N/A | N/A |